Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia — Sponsor Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

6 Recruiting

4 Completed trials

8 Countries active

20 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 3 Phase IV: 5

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Rectal cancer 1 Amyotrophic lateral sclerosis 1 Dilated cardiomyopathy 1 Pre-eclampsia 1 Colon cancer stage III 1 Colon cancer stage II 1 Ovarian cancer 1 Breast cancer 1 External cephalic version 1

Top IMPs

ACETYLSALICYLIC ACID 1 AMOXICILLIN, CLAVULANIC ACID 1 BISOPROLOL FUMARATE 1 BUPIVACAINE HYDROCHLORIDE 1 CABOTEGRAVIR 1 CEFDITOREN PIVOXIL 1 CEFUROXIME 1 CIPROFLOXACIN 1 CISPLATIN 1 COLCHICINE 1 EPLERENONE 1 FENTANYL CITRATE 1

All trials

10 total

Multicenter clinical trial on the effectiveness and safety of outpatient treatment of acute uncomplicated diverticulitis without antibiotics… Pending

2025-523121-17-00 Phase IV 1 country AMOXICILLIN, CLAVULANIC ACID; CEFDITOREN PIVOXIL; CEFUROXIME; CIPROFLOXACIN; MET…
Treatment with Risedronate for dilated cardiomyopathy due to Troponin T alteration due to K210 deletion. Recruiting

2023-509431-29-00 Phase II 1 country RISEDRONATE SODIUM
Randomized Clinical Trial of the use of Propofol as a sedative agent versus spinal analgesia with bupivacaine in External Cephalic Version (… Recruiting

2024-510701-29-00 Phase IV 1 country BUPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE; PROPOFOL
Aspirin versus placebo in twin pregnancies for preeclampsia prevention: A multicentre, randomised, double-blind, placebo-controlled trial (A… Recruiting

2023-503698-40-00 Phase III 7 countries ACETYLSALICYLIC ACID
Combined treatment of intraperitoneal chemotherapy after optimal interval surgery in advanced ovarian cancer. BICOV-1 (Bidirectional Chemoth… Recruiting

2022-502691-23-00 Phase IV 1 country CISPLATIN; PACLITAXEL
HIsTological and CLinical effects of Imipramine in the treatment of patients with cancer over-expressing Fascin1. (HITCLIF) Recruiting

2023-504943-15-00 Phase II 1 country IMIPRAMINE HYDROCHLORIDE
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis (TCIM-ELAII) Recruiting

2023-506215-17-00 Phase II 1 country
Long Acting Cabotegravir plus Rilpivirine in People Living with HIV-1 (PLHIV) Aged ≥ 60 Years for 96 weeks. Ended

2022-502882-53-00 Phase IV 1 country CABOTEGRAVIR; RILPIVIRINE
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE) Ended

2023-504946-70-00 Phase IV 1 country BISOPROLOL FUMARATE; EPLERENONE; FUROSEMIDE; VALSARTAN
Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure Ended

2023-504165-23-00 Phase III 2 countries COLCHICINE

Showing 1–10 of 10 trials

← All sponsors A–Z